[{"from": "human", "value": "Based on the given information, design a molecule that meets the desired specifications. The molecule is a partial agonist at neuronal nicotinic acetylcholine receptors, binding primarily to the \u03b14\u03b22 subtype. It was originally developed as a potential treatment for Alzheimer's disease for its nootropic effects but has also been found to inhibit the production of Interleukin-8. It has subsequently been developed as a potential anti-inflammatory treatment for ulcerative colitis. Rivanicline also has stimulant and analgesic actions which are thought due to increased noradrenaline release."}, {"from": "gpt", "value": "[C][N][C][C][/C][=C][/C][=C][N][=C][C][=C][Ring1][=Branch1]"}]